Stryker’s Insignia Hip Stem launched at the 2022 AAOS Meeting

The Joint Replacement Division of medical device company Stryker recently announced the introduction of their Insignia® Hip Stem at the 2022 Annual Meeting of the American Academy of Orthopoaedic Surgeons, which took lace in Chicago.
It has been designed to optimise patient fit and ease for the surgeon during implantation in muscle sparing approaches when conducting hemiarthroplasty and total hip procedures. Using Total Hip 4.1 software (allowing surgeons to capitalise on 3D CT-based data to capture the unique anatomy of each patient), the Insignia Hip Stem is compatible with Mako SmartRobotics™.

Capitalising on Stryker’s SOMA database (Stryker Orthopaedics Modelling and Analytics), the company analysed data from more than 1,300 patient CT scans, and strived to design a device which effectively re-creates biomechanics for procedures in patient total hip replacement.

A unique Tri-Stage™ Broach is offered by Insignia, which features 3 different tooth geometries, along with unique collar lengths (specific to size) and a superlative range of femoral offsets which have been designed to provide advanced fit and function over a wide breadth of of femoral morphology. Additionally, Insignia has a low profile shoulder and short stem lengths, which have been engineered to ease lateralization and insertion for use in muscle-sparing approaches such as direct anterior.

Katherine Truppi, the Vice President as well as General Manager for Hips at the Stryker corporation, had this to say:

“We’re excited to now offer surgeons a collared, fully HA-coated hip stem designed for muscle-sparing approaches like direct anterior. Insignia joins Stryker’s family of market-leading hip stems to complement our primary hip portfolio. Compatible with Mako SmartRobotics, Insignia delivers patient-specific fit, function and flexibility, allowing surgeons to further enhance patient outcomes.”

The Stryker company is is generating insights by enabling innovative products with digital capability, which help to drive improved operational, financial and clinical outcomes across the care profession.

Stryker has called this Advanced Digital Healthcare. It includes the capability extension of Mako SmartRobotics™ to procedures which utilise the Insignia Hip Stem. Stryker’s digital technologies are striving to make healthcare operations more personalised, precise and efficient, by using simple and secured connected platforms.
Throughout the 2022 Annual Meeting, the company, will also be holding live demonstrations, as well as exhibitions, and a lunch symposium which features Insignia and Advanced Digital Healthcare.

© Stryker Corporation
© American Academy of Orthopaedic Surgeons

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe